Lingyan Lv
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Nanoparticle-Based Drug Delivery 8
-
- RNA Interference and Gene Delivery 10
- Pluripotent Stem Cells Research 2
- Extracellular vesicles in disease 2
- Advanced biosensing and bioanalysis techniques 2
- Co-authors
- Hongliang Xin (14 shared papers)Wei Lv (9 shared papers)Qunwei Xu (7 shared papers)Yan Jiang (7 shared papers)Yue Zhao (6 shared papers)Zhongyuan Wang (5 shared papers)Baoyan Wang (5 shared papers)Lin Hai Wu (2 shared papers)
- Journals
- Journal of Controlled Release (3 papers)Scientific Reports (2 papers)European Heart Journal (2 papers)Reproductive Sciences (1 paper)Livestock Science (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lingyan Lv
25 papers receiving 868 citations
Peers
Comparison fields: 5 of 96
- Biomaterials 384
- Neurology 94
- Pharmaceutical Science 55
- Biomedical Engineering 285
- Developmental Neuroscience 24
Countries citing papers authored by Lingyan Lv
This map shows the geographic impact of Lingyan Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Lv more than expected).
Fields of papers citing papers by Lingyan Lv
This network shows the impact of papers produced by Lingyan Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Lv. The network helps show where Lingyan Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingyan Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 147 | |
| 2 | 2015 | 120 | |
| 3 | 2014 | 72 | |
| 4 | 2016 | 72 | |
| 5 | 2022 | 71 | |
| 6 | 2015 | 57 | |
| 7 | 2022 | 49 | |
| 8 | 2019 | 42 | |
| 9 | 2017 | 38 | |
| 10 | 2022 | 33 | |
| 11 | 2022 | 32 | |
| 12 | 2016 | 29 | |
| 13 | 2020 | 26 | |
| 14 | 2023 | 21 | |
| 15 | 2021 | 16 | |
| 16 | 2014 | 16 | |
| 17 | 2022 | 13 | |
| 18 | 2023 | 7 | |
| 19 | 2023 | 4 | |
| 20 | 2015 | 4 |
About Lingyan Lv
Lingyan Lv is a scholar working on Biomaterials, Molecular Biology, Biomedical Engineering, Immunology and Biological Psychiatry, having authored 27 papers that have together received 879 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (10 papers), Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (5 papers), Pluripotent Stem Cells Research (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), Reproductive Biology and Fertility (2 papers), Extracellular vesicles in disease (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Biomaterials (384 citations), Neurology (94 citations), Pharmaceutical Science (55 citations), Biomedical Engineering (285 citations) and Developmental Neuroscience (24 citations). Lingyan Lv has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Hongliang Xin, Wei Lv, Qunwei Xu, Yan Jiang, Yue Zhao, Zhongyuan Wang, Baoyan Wang, Lin Hai Wu, Shengnan Li and Xiuzhen Wang. Their work appears in journals such as Journal of Controlled Release, Scientific Reports, European Heart Journal, Reproductive Sciences and Livestock Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.